Abstract:In this pictorial review, we illustrate acquired diseases or conditions of the corpus callosum that may be found by magnetic resonance (MR) imaging of the brain, including infarction, bleeding, diffuse axonal injury, multiple sclerosis, acute disseminated encephalomyelitis, Marchiafava-Bignami disease, glioblastoma, gliomatosis cerebri, lymphoma, metastasis, germinoma, infections, metabolic diseases, transient splenial lesion, dilated Virchow-Robin spaces, wallerian degeneration after hemispheric damage and fo… Show more
“…The differential diagnosis of T2 hyperintense focal lesions in the corpus callosum splenium includes various demyelinating diseases (eg, Marchiafava-Bignami disease, encephalitis, osmotic myelinolysis, and transient splenial lesions). The etiologies of transient T2 hyperintense focal lesions in the splenium of the corpus callosum include patients with epilepsy treated with antiepileptic drugs, 35 acute infectious encephalitis (influenza, Escherichia coli, mumps, adenovirus, Epstein-Barr virus, and Rota virus), [36][37][38][39] demyelinating lesions including osmotic myelinolysis, and acute toxic encephalopathy (methotrexate and 5-fluorouracil). [40][41] The present study has several limitations.…”
BACKGROUND AND PURPOSE: MR imaging features of metronidazole-induced encephalopathy (MIE) have not been fully established. This study was undertaken to determine the topographic distributions and diffusion-weighted imaging (DWI) findings of MIE.
“…The differential diagnosis of T2 hyperintense focal lesions in the corpus callosum splenium includes various demyelinating diseases (eg, Marchiafava-Bignami disease, encephalitis, osmotic myelinolysis, and transient splenial lesions). The etiologies of transient T2 hyperintense focal lesions in the splenium of the corpus callosum include patients with epilepsy treated with antiepileptic drugs, 35 acute infectious encephalitis (influenza, Escherichia coli, mumps, adenovirus, Epstein-Barr virus, and Rota virus), [36][37][38][39] demyelinating lesions including osmotic myelinolysis, and acute toxic encephalopathy (methotrexate and 5-fluorouracil). [40][41] The present study has several limitations.…”
BACKGROUND AND PURPOSE: MR imaging features of metronidazole-induced encephalopathy (MIE) have not been fully established. This study was undertaken to determine the topographic distributions and diffusion-weighted imaging (DWI) findings of MIE.
“…They may also originate in the basal ganglia, cerebellopontine angle, lateral ventricle, cerebellum, frontal/temporal/occipital lobes, medulla, and, very rarely, in the corpus callosum. [1][2][3][4][5][6] Because of the unusual location of the lesion, multiple neuroradiologists failed to include germinoma in the differential diagnosis. …”
Section: Discussionmentioning
confidence: 99%
“…1 These tumours are believed to originate as a midline streaming of totipotential cells early in the development of the rostral part of the neural tube. 2,3 Clinical features depend on tumour location. For those located in the suprasellar region, the typical presentation is with diabetes insipidus, hypopituitarism, and bitemporal hemianopia.…”
A case is described of a young man presenting with diabetes insipidus and a junctional scotoma. A diffuse infiltrating mass centred in the corpus callosum and suprasellar area is found, which on pathological examination proved to be a primary intracranial germinoma. The case illustrates that rarely the corpus callosum can be involved by this tumour and that diagnosis may be delayed in atypical presentations.
“…Germ cell tumors including germinomas in the corpus callosum are very rare and are usually associated with other intracranial lesions. 1,7,9,11,[16][17][18][19][20] Only one of 153 germ cell tumors was located in the corpus callosum (0.7%). 11) The reason for the low incidence of germ cell tumors arising at the corpus callosum is unclear, but may be related to the pathogenesis of intracranial germ cell tumors.…”
Section: Introductionmentioning
confidence: 99%
“…Only 11 patients with germ cell tumors in the corpus callosum have been reported, 1,7,9,11,[16][17][18][19][20] all associated other intracranial lesions including disseminated periventricular tumors, adjacent cerebral parenchymal lesions, and so-called favorite site lesions (Table 1). Patients with corpus callosum germ cell tumors tended to be older (mean ± standard deviation [SD] 23.7 ± 10.9 years) than patients with more common intracranial germinomas.…”
A previously healthy 31-year-old Japanese man presented with a very rare germinoma of the corpus callosum without other intracranial lesions manifesting as transitory speech disturbance. Magnetic resonance (MR) imaging revealed a heterogeneously enhanced mass in the corpus callosum extending into the cavity of the septum pellucidum. A tumor specimen obtained by stereotactic biopsy revealed a two-cell pattern germinoma containing human chorionic gonadotropin (HCG)-b-positive giant cells. The cerebrospinal fluid and serum levels of HCG and HCG-b subunit were measurable. The diagnosis was germinoma with syncytiotrophoblastic giant cells. Three cycles of chemotherapy consisting of ifosfamide, cisplatin, and etoposide, followed by radiation therapy achieved complete remission, and 5 cycles of chemotherapy with carboplatin and etoposide were added. MR imaging performed 40 months after the diagnosis showed a cicatricial cyst in the body of the corpus callosum, the original tumor site. All 11 previously reported cases of germinoma in the corpus callosum were associated with synchronous or metachronous intracranial lesions. These patients tended to be older than patients with general intracranial germinoma. Germinoma should be included in the differential diagnosis of corpus callosum tumors, especially in young adult males.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.